Alterations of GABAB binding caused by acute and chronic lead administration
The effect of lead on GABAB binding was studied on membranes obtained from acute and chronically lead-treated rats. Acute lead treatment reduced both GABAB affinity (KD) by about 30% and density of receptor (Bmax) by about 15%. On the contrary chronic lead treatment increased receptor capacity by ab...
Gespeichert in:
Veröffentlicht in: | Acta neurobiologiae experimentalis 1996, Vol.56 (1), p.227-231 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 231 |
---|---|
container_issue | 1 |
container_start_page | 227 |
container_title | Acta neurobiologiae experimentalis |
container_volume | 56 |
creator | Waśkiewicz, J |
description | The effect of lead on GABAB binding was studied on membranes obtained from acute and chronically lead-treated rats. Acute lead treatment reduced both GABAB affinity (KD) by about 30% and density of receptor (Bmax) by about 15%. On the contrary chronic lead treatment increased receptor capacity by about 20% in spite of decreased receptor affinity by 25%. Both acute and chronic lead treatment shiffted displacement curves toward higher concentration of non-labelled compound (decreased affinity). The results show that lead can affect the GABAB binding in two ways: by reducing affinity of binding and by altering capacity of binding. |
doi_str_mv | 10.55782/ane-1996-1124 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_55782_ane_1996_1124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8787178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c205t-ad5d9413caeb8465185309f7ba8faaa9ecf891477456ee3213a7a8093e2774293</originalsourceid><addsrcrecordid>eNo90DtPwzAUBWALgUoprGxI_gMu16_YHtOKl1SJBeboxnbAqHWqOB3672lpxXSXe46OPkLuOcy1NlY8Yo6MO1cxzoW6IFNeWccApL4kU4BKM64ArslNKT8AwhgBEzKxxhpu7JSs6vUYBxxTnwvtO_pSL-oFbVMOKX9Rj7sSA233FP1ujBRzoP576HPydB0xUAyblFMZTw235KrDdYl35zsjn89PH8tXtnp_eVvWK-YF6JFh0MEpLj3G1qpKc6sluM60aDtEdNF31nFljNJVjFJwiQYtOBkP85Vwckbmp14_9KUMsWu2Q9rgsG84NH8qzUGlOao0R5VD4OEU2O7aTQz_72cG-Qv04F0I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Alterations of GABAB binding caused by acute and chronic lead administration</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Waśkiewicz, J</creator><creatorcontrib>Waśkiewicz, J</creatorcontrib><description>The effect of lead on GABAB binding was studied on membranes obtained from acute and chronically lead-treated rats. Acute lead treatment reduced both GABAB affinity (KD) by about 30% and density of receptor (Bmax) by about 15%. On the contrary chronic lead treatment increased receptor capacity by about 20% in spite of decreased receptor affinity by 25%. Both acute and chronic lead treatment shiffted displacement curves toward higher concentration of non-labelled compound (decreased affinity). The results show that lead can affect the GABAB binding in two ways: by reducing affinity of binding and by altering capacity of binding.</description><identifier>ISSN: 0065-1400</identifier><identifier>EISSN: 1689-0035</identifier><identifier>DOI: 10.55782/ane-1996-1124</identifier><identifier>PMID: 8787178</identifier><language>eng</language><publisher>Poland</publisher><subject>Animals ; Brain Chemistry - drug effects ; In Vitro Techniques ; Kinetics ; Lead - toxicity ; Male ; Rats ; Rats, Wistar ; Receptors, GABA-B - drug effects ; Receptors, GABA-B - metabolism ; Synaptosomes - metabolism</subject><ispartof>Acta neurobiologiae experimentalis, 1996, Vol.56 (1), p.227-231</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c205t-ad5d9413caeb8465185309f7ba8faaa9ecf891477456ee3213a7a8093e2774293</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8787178$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Waśkiewicz, J</creatorcontrib><title>Alterations of GABAB binding caused by acute and chronic lead administration</title><title>Acta neurobiologiae experimentalis</title><addtitle>Acta Neurobiol Exp (Wars)</addtitle><description>The effect of lead on GABAB binding was studied on membranes obtained from acute and chronically lead-treated rats. Acute lead treatment reduced both GABAB affinity (KD) by about 30% and density of receptor (Bmax) by about 15%. On the contrary chronic lead treatment increased receptor capacity by about 20% in spite of decreased receptor affinity by 25%. Both acute and chronic lead treatment shiffted displacement curves toward higher concentration of non-labelled compound (decreased affinity). The results show that lead can affect the GABAB binding in two ways: by reducing affinity of binding and by altering capacity of binding.</description><subject>Animals</subject><subject>Brain Chemistry - drug effects</subject><subject>In Vitro Techniques</subject><subject>Kinetics</subject><subject>Lead - toxicity</subject><subject>Male</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, GABA-B - drug effects</subject><subject>Receptors, GABA-B - metabolism</subject><subject>Synaptosomes - metabolism</subject><issn>0065-1400</issn><issn>1689-0035</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90DtPwzAUBWALgUoprGxI_gMu16_YHtOKl1SJBeboxnbAqHWqOB3672lpxXSXe46OPkLuOcy1NlY8Yo6MO1cxzoW6IFNeWccApL4kU4BKM64ArslNKT8AwhgBEzKxxhpu7JSs6vUYBxxTnwvtO_pSL-oFbVMOKX9Rj7sSA233FP1ujBRzoP576HPydB0xUAyblFMZTw235KrDdYl35zsjn89PH8tXtnp_eVvWK-YF6JFh0MEpLj3G1qpKc6sluM60aDtEdNF31nFljNJVjFJwiQYtOBkP85Vwckbmp14_9KUMsWu2Q9rgsG84NH8qzUGlOao0R5VD4OEU2O7aTQz_72cG-Qv04F0I</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>Waśkiewicz, J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1996</creationdate><title>Alterations of GABAB binding caused by acute and chronic lead administration</title><author>Waśkiewicz, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c205t-ad5d9413caeb8465185309f7ba8faaa9ecf891477456ee3213a7a8093e2774293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Brain Chemistry - drug effects</topic><topic>In Vitro Techniques</topic><topic>Kinetics</topic><topic>Lead - toxicity</topic><topic>Male</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, GABA-B - drug effects</topic><topic>Receptors, GABA-B - metabolism</topic><topic>Synaptosomes - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Waśkiewicz, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Acta neurobiologiae experimentalis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Waśkiewicz, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations of GABAB binding caused by acute and chronic lead administration</atitle><jtitle>Acta neurobiologiae experimentalis</jtitle><addtitle>Acta Neurobiol Exp (Wars)</addtitle><date>1996</date><risdate>1996</risdate><volume>56</volume><issue>1</issue><spage>227</spage><epage>231</epage><pages>227-231</pages><issn>0065-1400</issn><eissn>1689-0035</eissn><abstract>The effect of lead on GABAB binding was studied on membranes obtained from acute and chronically lead-treated rats. Acute lead treatment reduced both GABAB affinity (KD) by about 30% and density of receptor (Bmax) by about 15%. On the contrary chronic lead treatment increased receptor capacity by about 20% in spite of decreased receptor affinity by 25%. Both acute and chronic lead treatment shiffted displacement curves toward higher concentration of non-labelled compound (decreased affinity). The results show that lead can affect the GABAB binding in two ways: by reducing affinity of binding and by altering capacity of binding.</abstract><cop>Poland</cop><pmid>8787178</pmid><doi>10.55782/ane-1996-1124</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0065-1400 |
ispartof | Acta neurobiologiae experimentalis, 1996, Vol.56 (1), p.227-231 |
issn | 0065-1400 1689-0035 |
language | eng |
recordid | cdi_crossref_primary_10_55782_ane_1996_1124 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Animals Brain Chemistry - drug effects In Vitro Techniques Kinetics Lead - toxicity Male Rats Rats, Wistar Receptors, GABA-B - drug effects Receptors, GABA-B - metabolism Synaptosomes - metabolism |
title | Alterations of GABAB binding caused by acute and chronic lead administration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T06%3A11%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20of%20GABAB%20binding%20caused%20by%20acute%20and%20chronic%20lead%20administration&rft.jtitle=Acta%20neurobiologiae%20experimentalis&rft.au=Wa%C5%9Bkiewicz,%20J&rft.date=1996&rft.volume=56&rft.issue=1&rft.spage=227&rft.epage=231&rft.pages=227-231&rft.issn=0065-1400&rft.eissn=1689-0035&rft_id=info:doi/10.55782/ane-1996-1124&rft_dat=%3Cpubmed_cross%3E8787178%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8787178&rfr_iscdi=true |